Immunocore Holdings plc American Depositary Shares is a clinical-stage biotechnology company focused on developing innovative T-cell receptor (TCR) based immunotherapies. With a proprietary platform, the company aims to target a wide range of diseases including cancer, infectious diseases, and autoimmune disorders. ImmunoCore’s unique approach has the potential to revolutionize the field of immunotherapy and improve patient outcomes.
